Probing popular and political discourse on antimicrobial resistance in China

[1] Davies J(2010)Origins and evolution of antibiotic resistance Microbiol Mol Biol Rev 74 417-433

[2] Davies D(2013)Antimicrobial resistance: a global view from the 2013 world healthcare-associated infections forum Antimicrob Resist Infect Control 2 31-6782

[3] Huttner A(2015)Comprehensive evaluation of antibiotics emission and fate in the river basins of China: source analysis, multimedia modeling, and linkage to bacterial resistance Environ Sci Technol 49 6772-168

[4] Harbarth S(2016)Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study Lancet Infect Dis 16 161-10

[5] Carlet J(2006)MRSA—the tip of the iceberg Clin Microbiol Infect 12 3-229

[6] Cosgrove S(2008)In vitro activity of ceftobiprole, linezolid, tigecycline, and 23 other antimicrobial agents against Staphylococcus aureus isolates in China Diagn Microbiol Infect Dis 62 226-1218

[7] Goossens H(2016)Addressing antimicrobial resistance in China: policy implementation in a complex context Glob Health 12 30-733

[8] Holmes A(2016)China’s national plan to combat antimicrobial resistance Lancet Infect Dis 16 1216-1034

[9] Zhang Q-Q(2018)Evaluation and learning in complex, rapidly changing health systems: China’s management of health sector reform Glob Health 14 112-36

[10] Ying G-G(2017)Chinese health care system and clinical epidemiology Clinical Epidemiology 9 167-876

[1] Davies J(2010)Origins and evolution of antibiotic resistance Microbiol Mol Biol Rev 74 417-433

[2] Davies D(2013)Antimicrobial resistance: a global view from the 2013 world healthcare-associated infections forum Antimicrob Resist Infect Control 2 31-6782

[3] Huttner A(2015)Comprehensive evaluation of antibiotics emission and fate in the river basins of China: source analysis, multimedia modeling, and linkage to bacterial resistance Environ Sci Technol 49 6772-168

[4] Harbarth S(2016)Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study Lancet Infect Dis 16 161-10

[5] Carlet J(2006)MRSA—the tip of the iceberg Clin Microbiol Infect 12 3-229

[6] Cosgrove S(2008)In vitro activity of ceftobiprole, linezolid, tigecycline, and 23 other antimicrobial agents against Staphylococcus aureus isolates in China Diagn Microbiol Infect Dis 62 226-1218

[7] Goossens H(2016)Addressing antimicrobial resistance in China: policy implementation in a complex context Glob Health 12 30-733

[8] Holmes A(2016)China’s national plan to combat antimicrobial resistance Lancet Infect Dis 16 1216-1034

[9] Zhang Q-Q(2018)Evaluation and learning in complex, rapidly changing health systems: China’s management of health sector reform Glob Health 14 112-36

[10] Ying G-G(2017)Chinese health care system and clinical epidemiology Clinical Epidemiology 9 167-876